首页> 美国卫生研究院文献>Global Pediatric Health >Barriers to Pediatric Sickle Cell Disease Guideline Recommendations
【2h】

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations

机译:小儿镰状细胞病指南建议的障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

National guidelines recommend that providers counsel all patients with sickle cell anemia about hydroxyurea (HU) therapy and screen children with sickle cell anemia annually for the risk of stroke with transcranial Doppler (TCD). We surveyed a national convenience sample of sickle cell disease clinicians to assess factors associated with low adherence. Adherence was 46% for TCD screening. Low adherence was associated with a lack of outcome expectancy (eg, a belief that there would be poor patient follow-up to TCD testing; P < .05). Adherence was 72% for HU counseling. Practice barriers (eg, lack of support staff or time) and a lack of agreement with HU recommendations were associated with low adherence (P < .05). This study demonstrates that different types of strategies are needed to improve TCD screening (to address follow-up and access to testing) versus HU counseling (to address physician agreement and practice barriers).
机译:国家指南建议医疗服务提供者对所有镰状细胞性贫血患者进行羟基脲(HU)治疗的咨询,并每年对镰状细胞性贫血儿童进行经颅多普勒(TCD)筛查。我们调查了镰状细胞病临床医生的全国便利性样本,以评估与依从性低相关的因素。 TCD筛查的依从性为46%。依从性差与缺乏预期结果有关(例如,认为患者对TCD测试的随访不良; P <.05)。 HU咨询的坚持率为72%。实践障碍(例如,缺乏支持人员或时间)以及缺乏与HU的建议达成一致与坚持率低有关(P <.05)。这项研究表明,相对于HU咨询(解决医生的共识和实践障碍),需要采取不同类型的策略来改善TCD筛查(解决随访和获得测试的机会)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号